The human glucagon-like peptide-1 analogue liraglutide preserves pancreatic beta cells via regulation of cell kinetics and suppression of oxidative and endoplasmic reticulum stress in a mouse model of diabetes.
about
An Update on the Effect of Incretin-Based Therapies on β-Cell Function and MassAcarbose: safe and effective for lowering postprandial hyperglycaemia and improving cardiovascular outcomesEndoplasmic Reticulum Stress in the Diabetic Kidney, the Good, the Bad and the UglyLost in translation: endoplasmic reticulum stress and the decline of β-cell health in diabetes mellitusLipotoxicity in the pancreatic beta cell: not just survival and function, but proliferation as well?Liraglutide improves pancreatic Beta cell mass and function in alloxan-induced diabetic miceLiraglutide administration in type 2 diabetic patients who either received no previous treatment or were treated with an oral hypoglycemic agent showed greater efficacy than that in patients switching from insulinThe albumin-exendin-4 recombinant protein E2HSA improves glycemic control and β-cell function in spontaneous diabetic KKAy mice.Exendin-4 and sitagliptin protect kidney from ischemia-reperfusion injury through suppressing oxidative stress and inflammatory reaction.Inhibition of dipeptidyl peptidase-IV enzyme activity protects against myocardial ischemia-reperfusion injury in rats.Acarbose, lente carbohydrate, and prebiotics promote metabolic health and longevity by stimulating intestinal production of GLP-1.Determining predictors of early response to exenatide in patients with type 2 diabetes mellitusCharacterisation of age-dependent beta cell dynamics in the male db/db mice.Effects of the glucagon-like peptide-1 receptor agonist liraglutide in juvenile transgenic pigs modeling a pre-diabetic conditionExendin-4 protected against critical limb ischemia in obese miceAmelioration of glucolipotoxicity-induced endoplasmic reticulum stress by a "chemical chaperone" in human THP-1 monocytes.Liraglutide protects pancreatic β-cells against free fatty acids in vitro and affects glucolipid metabolism in apolipoprotein E-/- mice by activating autophagy.ER Stress and β-Cell Pathogenesis of Type 1 and Type 2 Diabetes and Islet Transplantation.Glucagon-Like Peptide-1 Analog Liraglutide Protects against Diabetic Cardiomyopathy by the Inhibition of the Endoplasmic Reticulum Stress Pathway.Npas4 is a novel activity-regulated cytoprotective factor in pancreatic β-cells.Maternal ileal interposition surgery confers metabolic improvements to offspring independent of effects on maternal body weight in UCD-T2DM rats.Does Glucagon-like Peptide-1 Ameliorate Oxidative Stress in Diabetes? Evidence Based on Experimental and Clinical Studies.The Time Is Right for a New Classification System for Diabetes: Rationale and Implications of the β-Cell-Centric Classification Schema.Sitagliptin prevents aggravation of endocrine and exocrine pancreatic damage in the Zucker Diabetic Fatty rat - focus on amelioration of metabolic profile and tissue cytoprotective propertiesThe role of autophagy in endoplasmic reticulum stress-induced pancreatic β cell death.Autophagy regulates insulin resistance following endoplasmic reticulum stress in diabetes.Appropriate therapy for type 2 diabetes mellitus in view of pancreatic β-cell glucose toxicity: "the earlier, the better".The Clinical Use of a Fixed-Dose Combination of Insulin Degludec and Liraglutide (Xultophy 100/3.6) for the Treatment of Type 2 Diabetes.Therapeutic Targeting of Cellular Stress to Prevent Cardiovascular Disease: A Review of the Evidence.Protective action of liraglutide in beta cells under lipotoxic stress via PI3K/Akt/FoxO1 pathway.Establishment of a pancreatic β cell proliferation model in vitro and a platform for diabetes drug screeningBeta cell specific probing with fluorescent exendin-4 is progressively reduced in type 2 diabetic mouse models.Liraglutide and DPP-4 inhibitors - side effects comparative clinical study.DPP-4 enzyme deficiency protects kidney from acute ischemia-reperfusion injury: role for remote intermittent bowel ischemia-reperfusion preconditioning.RETRACTED: Therapeutic stimulation of GLP-1 and GIP protein with DPP-4 inhibitors for type-2 diabetes treatment.Improvement of islet graft function using liraglutide is correlated with its anti-inflammatory properties.Sodium fluorocitrate having protective effect on palmitate-induced beta cell death improves hyperglycemia in diabetic db/db miceβ-cell preservation and regeneration for diabetes treatment: where are we now?Liraglutide Improves the Survival of INS-1 Cells by Promoting Macroautophagy.Vildagliptin preserves the mass and function of pancreatic β cells via the developmental regulation and suppression of oxidative and endoplasmic reticulum stress in a mouse model of diabetes.
P2860
Q26749089-EA1F4B52-97B8-49DC-9A88-8E6542D03055Q26778095-7AB38047-EC6E-459A-ABBF-1B9C3BC36F7AQ26799567-B92C6BEC-DE40-4E71-A119-1A25C9460480Q26864403-1928DBCC-E024-4916-80B0-42EA9CCE8CFDQ26866054-7EA4F654-7F23-415A-9E7C-3F7BB25D281FQ28546996-94867588-D194-4F5B-9770-EC891FD9DE00Q33603478-278F5C7B-3716-4935-BD9A-1E24EE3F42CBQ33815267-1DAC8121-5490-4D75-B6EF-04E98E7923C2Q34508051-272A1904-E86F-4234-BC78-7BD9AD26F701Q34993368-5CF3C041-EF5A-40A9-896D-BCE1AE84F874Q35047406-5F72C9A5-CF75-44B5-93C5-842731C0D8E0Q35061423-FC3F3734-B7EC-40E2-A741-88369B0D83EDQ35064311-5AB2742F-3003-492D-A5C6-99B6F61E7FB2Q35184904-D9EC1A12-0429-4C9A-8C2D-95CA1CF55140Q35653491-DA7C8964-A019-422A-BC66-25D25CAACB55Q35895767-18B9995F-406D-4C30-8D28-89713B3705DDQ35919653-A889E0DC-4CD4-4B07-88F1-84F15403FAADQ36523562-BC2C7F60-4B34-4E15-AE0D-DD2345288519Q36825702-8CEFEB35-1667-4164-93E2-552B04D8D931Q37031010-17CCB258-E014-4570-87F0-0628BA565B38Q37372987-F7795010-D6D2-403F-81D1-EBC7F4766BBFQ37402790-99104E06-B570-4F6A-ADA6-F376C3E50976Q37652799-8C9241E6-DEDD-4EB0-A80C-4B1B57927BDDQ37720797-0610F4D7-2AB3-48BD-BF08-744D2965AC96Q37976952-00403678-D952-44AC-8AA7-2B8D69A6DB41Q38336391-93E4B330-D36B-4353-A9EA-4917B0F1D1E1Q38557038-4E2A698B-16E3-4B8E-9769-F0FBF7BBDA37Q38629197-6EFADD31-70DE-4DAF-9F74-A26191F6610AQ38990014-0D8D9DF9-3575-4E70-8ABB-39D3AE601824Q39035190-B2E0A731-AC74-4991-9A27-682229A68539Q39361030-8FEBB7A4-FA20-4299-9925-BB4B67EEDB19Q39932172-7F21F1B2-4E09-4713-8FCA-2F71D02B598CQ40363153-14724B12-699B-4384-A9A6-B0A22B250405Q41550500-CECED4EA-F096-487D-9C28-962F70AE78EFQ42105494-AEF8A019-7425-44E8-A07C-4D530BBD7F20Q42364488-8E9027F4-4CD7-4112-91D4-DB2804F47F60Q42374211-844D389E-B428-4A6E-BD16-56A7A75D4E8EQ42535316-4A0E4FC6-38C4-450A-B2B3-C2A214EBB751Q42812444-6D2073D3-8F7E-49B8-AF84-76673C23F63AQ43070817-97C506B9-9847-4DBF-BAEA-250EE916661B
P2860
The human glucagon-like peptide-1 analogue liraglutide preserves pancreatic beta cells via regulation of cell kinetics and suppression of oxidative and endoplasmic reticulum stress in a mouse model of diabetes.
description
2011 nî lūn-bûn
@nan
2011 թուականի Փետրուարին հրատարակուած գիտական յօդուած
@hyw
2011 թվականի փետրվարին հրատարակված գիտական հոդված
@hy
2011年の論文
@ja
2011年論文
@yue
2011年論文
@zh-hant
2011年論文
@zh-hk
2011年論文
@zh-mo
2011年論文
@zh-tw
2011年论文
@wuu
name
The human glucagon-like peptid ...... in a mouse model of diabetes.
@ast
The human glucagon-like peptid ...... in a mouse model of diabetes.
@en
type
label
The human glucagon-like peptid ...... in a mouse model of diabetes.
@ast
The human glucagon-like peptid ...... in a mouse model of diabetes.
@en
prefLabel
The human glucagon-like peptid ...... in a mouse model of diabetes.
@ast
The human glucagon-like peptid ...... in a mouse model of diabetes.
@en
P2093
P2860
P1433
P1476
The human glucagon-like peptid ...... in a mouse model of diabetes.
@en
P2093
K Tawaramoto
M Hashiramoto
S Hamamoto
P2860
P2888
P304
P356
10.1007/S00125-011-2069-9
P577
2011-02-22T00:00:00Z
P5875
P6179
1036385768